AdvanCell Announces First Patient Dosed in Phase I/II TheraPb Clinical Trial of 212Pb-ADVC001 in Metastatic Prostate Cancer
SYDNEY--(BUSINESS WIRE)--AdvanCell, a radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for cancer patients,…